LexBlog IP

MARCH 8, 2023

We also have an upcoming webinar covering the topic in March – details here.) What seems clear is that NAD is reading this document with a fine-tooth comb, and one can expect to see this guidance followed to a tee as far as what is expected from advertisers for all manner of health claim substantiation. We shall see.

Advertising 52

Advertising Advertising Branding Brands 52

Patently-O

FEBRUARY 15, 2023

The Federal Circuit weighed in on the amorphous topic of subject matter eligibility in the recent opinion ChromaDex, Inc., When ingested, a human body converts NR into the coenzyme nicotinamide adenine dinucleotide, or NAD+. He has an extensive background in chemistry and food science. Elysium Health, Inc. , — F.4th

Patent 54

Patent Patent Drafting IP Law 54

LexBlog IP

NOVEMBER 7, 2022

Seyfarth’s topics include: Advertising Litigation Developments. ET, Seyfarth will take the main stage to present a session that will address significant developments over the past year in advertising litigation, including consumer fraud class actions, Lanham Act cases, and NAD challenges. On Thursday, November 10 at 11:05 a.m.

Advertising 40

Advertising Advertising Marketing Marketing 40

43(B)log

DECEMBER 20, 2021

Challenged claims include: Defendant’s frankincense oil “promotes feelings of relaxation & tranquility”; Defendant’s lavender oil “promote[s] feeling of calm and fight[s] occasional nervous tension’ and has ‘balancing properties that calm the mind and body”; Defendant’s peppermint oil “helps to maintain energy levels when applied topically.”

Advertising 90

Advertising Advertising Blogging False Advertising 90

43(B)log

FEBRUARY 17, 2022

While surveys should control for demand effects, the surveys here didn’t suggest to consumers what the “right” answer was, only what the relevant topic was. “[T]he test/control stimuli His survey population differed somewhat as did the control group/questions.

False Advertising 59

False Advertising Advertising Advertising Social Media 59